Self-Deletion of AAV-CRISPR Reduces Off-Target Gene Editing In Vivo

被引：0
|
作者：
Li, Ang [1 ]
Lee, Ciaran M. [1 ]
Hurley, Ayrea E. [2 ]
Lu, Weiqi [1 ]
De Giorgi, Marco [2 ]
Jarrett, Kelsey E. [2 ]
Doerfler, Alexandria M. [2 ]
Deshmukh, Harshavardhan [1 ]
Lagor, William R. [2 ]
Bao, Gang [1 ]
机构：
[1] Rice Univ, Bioengn, Houston, TX USA
[2] Baylor Coll Med, Mol Physiol & Biophys, Houston, TX 77030 USA
来源：
MOLECULAR THERAPY | 2019年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
168
引用
收藏
页码：89 / 89
页数：1
相关论文
共 50 条
  • [21] Beyond the promise: evaluating and mitigating off-target effects in CRISPR gene editing for safer therapeutics
    Lopes, Rui
    Prasad, Megana K.
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2024, 11
  • [22] Battling CRISPR-Cas9 off-target genome editing
    Daisy Li
    Hong Zhou
    Xiao Zeng
    Cell Biology and Toxicology, 2019, 35 : 403 - 406
  • [23] Off-Target Editing by CRISPR-Guided DNA Base Editors
    Park, SeHee
    Beal, Peter A.
    BIOCHEMISTRY, 2019, 58 (36) : 3727 - 3734
  • [24] Battling CRISPR-Cas9 off-target genome editing
    Li, Daisy
    Zhou, Hong
    Zeng, Xiao
    CELL BIOLOGY AND TOXICOLOGY, 2019, 35 (05) : 403 - 406
  • [25] Advances in Off-Target Detection for CRISPR-Based Genome Editing
    Wang, Haozheng
    Wang, Yangmin
    Luo, Zhongtao
    Lin, Xinjian
    Liu, Meilin
    Wu, Fenglin
    Shao, Hongwei
    Zhang, Wenfeng
    HUMAN GENE THERAPY, 2023, 34 (3-4) : 112 - 128
  • [26] Assessing Off-Target Editing of CRISPR-Cas9 Systems
    Pruett-Miller, Shondra M.
    CRISPR JOURNAL, 2020, 3 (06): : 430 - 432
  • [27] AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9
    Li, Ang
    Tanner, Mark R.
    Lee, Ciaran M.
    Hurley, Ayrea E.
    De Giorgi, Marco
    Jarrett, Kelsey E.
    Davis, Timothy H.
    Doerfler, Alexandria M.
    Bao, Gang
    Beeton, Christine
    Lagor, William R.
    MOLECULAR THERAPY, 2020, 28 (06) : 1432 - 1441
  • [28] AAV-CRISPR Gene Editing is Negated by Pre-Existing Immunity to Cas9
    Li, Ang
    Lee, Ciaran M.
    Tanner, Mark R.
    Hurley, Ayrea E.
    De Giorgi, Marco
    Jarrett, Kelsey E.
    Davis, Timothy H.
    Doerfler, Alexandria M.
    Bao, Gang
    Beeton, Christine
    Lagor, William R.
    MOLECULAR THERAPY, 2020, 28 (04) : 565 - 566
  • [29] Comprehensive Evaluation for Off-Target Editing of In Vivo Base Editing Medicines Targeting the PCSK9 Gene
    Bellinger, Andrew M.
    Kathiresan, Sekar
    Jayaram, Hari
    MOLECULAR THERAPY, 2022, 30 (04) : 89 - 89
  • [30] Minimizing off-target effects in CRISPR-Cas9 genome editing
    Shi-Jie Chen
    Cell Biology and Toxicology, 2019, 35 : 399 - 401
12345